Impact of PCSK9 inhibitors on the quality of life of patients at high cardiovascular risk

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of preventive cardiology 2020-03, Vol.27 (5), p.556-558
Hauptverfasser:	Cesaro, Arturo, Gragnano, Felice, Fimiani, Fabio, Moscarella, Elisabetta, Diana, Vincenzo, Pariggiano, Ivana, Concilio, Claudia, Natale, Francesco, Limongelli, Giuseppe, Bossone, Eduardo, Calabrò, Paolo
Format:	Artikel
Sprache:	eng
Schlagworte:	Activities of Daily Living Aged Anticholesteremic Agents - therapeutic use Biomarkers - blood Cardiovascular Diseases - diagnosis Cardiovascular Diseases - etiology Cardiovascular Diseases - prevention & control Cholesterol, LDL - blood Drug Therapy, Combination Female Health Status Heart Disease Risk Factors Humans Hypercholesterolemia - blood Hypercholesterolemia - complications Hypercholesterolemia - diagnosis Hypercholesterolemia - drug therapy Male Mental Health Middle Aged Proprotein Convertase 9 - antagonists & inhibitors Prospective Studies Quality of Life Risk Assessment Serine Proteinase Inhibitors - adverse effects Serine Proteinase Inhibitors - therapeutic use Surveys and Questionnaires Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!